Short CV/Education and training


  • Since 2015
    Retired, Invited Scientist, Honorary President of the International Network and of the Virology Department of the Institut Pasteur

  • 2005 – 2015
    Head of the “Regulation of Retroviral Infections” Unit, Institut Pasteur, Paris

  • 1992 – 2004
    Head of the Retrovirus Biology Unit, Institut Pasteur, Paris, France

  • 1986
    - 1991 Head of the Retrovirus Biology Laboratory, Institut Pasteur, Paris, France

  • Since 1988
    Successively, Associate Professor, then Professor (since 1996) at the Institut Pasteur

  • Since 1976
    Successively Assistant Professor, Associate Professor (1986) and Professor (1991) at the National Institute of Scientific and Medical Research (INSERM), France

International postgraduate experiences

  • 1979
    Laboratory of Dr. R. GALLO National Cancer Institute Bethesda, NIH (USA)

  • 1975 – 1976
    Postdoctoral fellows of the National Science Foundation, Laboratory of Dr. R.H. BASSIN, NIH, Bethesda (USA).

  • 1973
    Laboratory of Prof. P.FISCHINGER National Cancer Institute, NIH (USA)


  • 1974
    Ph.D. in Virology, Institut Pasteur and University of Science, Paris 7

  • 1972
    Master Degree in Biochemistry, University of Science, Paris 7

Selected publications

  • BARRÉ-SINOUSSI F., CHERMANN J.-C., REY F., NUGEYRE M.-T., CHAMARET S., GRUEST J., DAUGUET C., AXLER-BLIN C., BRUN-VEZINET F., ROUZIOUX C., ROZENBAUM W. & MONTAGNIER L. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science, 1983, 220, 868-871.

  • ALIZON M., SONIGO P., BARRÉ-SINOUSSI F., CHERMANN J.-C., TIOLLAIS P., MONTAGNIER L. & WAIN-HOBSON S. Molecular cloning of lymphadenopathy associated virus. Nature, 1984, 312, 757-760.

  • BRUN-VEZINET F., ROUZIOUX C., BARRÉ-SINOUSSI F., KLATZMANN D., SAIMOT A.G., ROZENBAUM W., CHRISTOL D., GLUCKMAN J.-C., MONTAGNIER L. & CHERMANN J.-C., F. BARRE-SINOUSSI & G. PANCINO. Increased NK Cell Activity in HIV-1 Exposed but Uninfected Vietnamese Intravascular Drug users J. Immunology 2003, 171 :5663-5667

  • 04 KORNFELD C, PLOQUIN MJ, PANDREA I, FAYE A, ONANGA R, APETREI C, POATY- MAVOUNGOU V, ROUQUET P, ESTAQUIER J, MORTARA L, DESOUTTER JF, BUTOR C, LE GRAND R, ROQUES P, SIMON F, BARRE-SINOUSSI F, DIOP OM, MULLER-TRUTWIN MC. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J. Clin. Invest. 2005. 115 (4): 1082-1091

  • SAEZ-CIRION A, LACABARATZ C, LAMBOTTE O, VERSMISSE P, URRUTIA A, BOUFASSA F, BARRE- SINOUSSI F, DELFRAISSY JF, SINET M, PANCINO G, VENET A. 2007. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar CTL activation phenotype. PNAS, 2007 104, 6776-6781

  • JACQUELIN B, MAYAU V, TARGAT B, LIOVAT AS, KUNKEL D, PETITJEAN G, DILLIES MA, ROQUES P, BUTOR C, SILVESTRI G, GIAVEDONI LD, LEBON P, BARRE-SINOUSSI F, BENECKE A, MÜLLER-TRUTWIN MC. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest. 2009, Dec;119(12):3544-55.

  • SAEZ-CIRION A, HAMIMI C, BERGAMASCHI A, DAVID A, VERSMISSE P, MELARD A, BOUFASSA F, BARRE-SINOUSSI F, LAMBOTTE O, ROUZIOUX C, PANCINO G; ANRS CO18 COHORT. Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers. Blood. 2011; 118(4):955-64

  • PEAN P, NERRIENET E, MADEC Y, BORAND L, LAUREILLARD D, FERNANDEZ M, MARCY O, SARIN C, PHON K, TAYLOR S, PANCINO G, BARRE-SINOUSSI F, SCOTT-ALGARA D; CAMBODIAN EARLY VERSUS LATE INTRODUCTION OF ANTIRETROVIRAL DRUGS (CAMELIA) STUDY TEAM. Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis. Blood. 2012 Apr 5;119(14):3315-20.

  • Chevalier MF, Petitjean G, Dunyach-Rémy C, Didier C, Girard PM, Manea ME, Campa P, Meyer L, Rouzioux C, Lavigne JP, BARRE-SINOUSSI F, Scott-Algara D, Weiss L. The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation. PLoS Pathog. 2013;9(6):e1003453.

  • BARRE-SINOUSSI F, ROSS AL, DELFRAISSY JF. Past, present and future: 30 years of HIV research. Nat Rev Microbiol. 2013 Dec;11(12):877-83.

Membership in scientific bodies/juries


  • Member of the INSERM Governing Board, since 2016

  • Honorary President of the Virology Department, Institut Pasteur, since 2015

  • Member of the «AmFar HIV Cure Council», since 2014

  • Member of the «UNAIDS Scientific Expert Panel», since 2014

  • Member of the «Governing Board of the HIV Cure Public-Private Partnership, Initiative» on HIV Cure («Annenberg Initiative»), since 2014

  • Member of the «Expert Advisory Panel on HIV» of the Bill and Melinda Gates, since 2013

  • Member of the reviewing committee of the Raymond Dedonder Award, since 2012

  • President of Honor of the Institut Pasteur International Network, since 2010

  • Co-chair of the Ethical Committee, Institut Pasteur, 2007 – 2012

  • Scientific advisor of the Institut Pasteur-TOTAL Foundation partnership, since 2005

  • Member of the Board of Directors, ANRS, since 2005

  • President of the International Scientific Advisory Board, ANRS, since 2003


You can only see the contact information of the academics in the database if you are a registered user of AcademiaNet.
Please register here


  1. Read what our members say about AcademiaNet.

Follow us

Similar profiles

  1. Prof. Patrizia Agostinis

    Biological and related sciences, Health, Cell Biology, Cellular signaling, Cancer biology, Cancer therapy

  2. Prof. Lital Alfonta

    Biological and related sciences, Physical sciences, Bioelectrochemistry, Synthetic Biology, Chemical Biology

  3. PhD Mar Albà

    Biological and related sciences, Evolution, genomics, bioinformatics

  4. PhD Sonja Aits

    Biological and related sciences, cell biology, molecular biology, biomedicine

Academia Net